Tavares
TL1 Member · Kuopio, FI
Newer member working through the reference pages before asking anything.
Joined 11 November 2025 · last posted 10d
38 posts, newest first. Showing up to 150.
-
Coming back to: Delayed gastric emptying and oral medication absorption: which drugs… Replied, post #38 · Practice › Interactions · 18 Jul 2026 · 0 likes Post #34 put the caveat in the right place and I want to underline it. Anticoagulant questions come up regularly and are the clearest case for professional advice…
-
Common supplements people ask about, assessed one at a time Replied, post #48 · Practice › Interactions · 15 Jul 2026 · 24 likes Narrowing post #45, because the general version has more than one answer. If someone has run common supplements properly I would rather read that than my own…
-
Follow-up: How compounding permissions changed when supply normalised Replied, post #20 · Sourcing › Regulatory · 14 Jul 2026 · 0 likes Nothing in this subcategory is legal advice, and the members who work in regulated environments are the most careful to say so.
-
I joined for one answer and stayed for a year — what changed my mind Replied, post #12 · Start Here › Welcome · 8 Jun 2026 · 12 likes You do not need to introduce yourself before asking a question, and nobody will think worse of you for arriving with one. The introductions subcategory exists for…
-
Revisiting: Mean kinetic temperature explained without the mathematics Replied, post #71 · Practice › Storage & stability · 2 Jun 2026 · 5 likes The arithmetic in post #68 is right; the assumption feeding it is the part to check. Mean kinetic temperature sits at the boundary between what this community can…
-
Oral versus injectable exposure: comparing apples to a different fruit — a second dataset Replied, post #18 · Compounds › Oral incretins · 19 May 2026 · 0 likes Timing consistency matters more for oral dosing than for weekly injection, because absorption depends on the state of the stomach and the state of the stomach varies…
-
A 5 mg vial and a 0.25 mg dose: the arithmetic in full Replied, post #46 · Practice › Reconstitution · 15 May 2026 · 30 likes Swirling until fully clear before drawing is worth the extra minute. A partially dissolved preparation is not uniform and the first dose out of it is not the same as…
-
Journal club: is percentage weight change the right endpoint? Replied, post #100 · Evidence › Journal club · 24 Apr 2026 · 15 likes Reading order that works for these sessions: registry entry, methods, baseline table, primary result, then abstract last. Reading the abstract first anchors everything…
-
Choosing which test to pay for, given a fixed budget Replied, post #54 · Sourcing › Independent verification · 4 Apr 2026 · 2 likes The arithmetic in post #52 is right; the assumption feeding it is the part to check. Repeat testing: if you want to verify the same lot a second time, testing with a…
-
Forced degradation studies: designing one that is informative Replied, post #15 · Analytics › Method validation · 5 Mar 2026 · 0 likes I would keep forced degradation studies and the decision it usually gets used for separate in this thread. They are related and they are not the same question, and…
-
Pre-registering a personal experiment, seriously — a second dataset Replied, post #36 · Research Methods › N-of-1 designs · 25 Feb 2026 · 14 likes Reporting the whole series rather than the interesting segment is the discipline that makes personal data worth reading. Selective reporting is the default without…
-
Lean mass preservation: what the evidence supports — does this still hold? Replied, post #22 · Outcomes › Body composition · 3 Feb 2026 · 26 likes Worth stating the null on Lean mass preservation before we explain it: the observation may be nothing. That possibility deserves a sentence and usually does not get one.
-
Revisiting: A page that has drifted out of date and needs a maintainer Replied, post #51 · Documentation › Wiki requests · 23 Jan 2026 · 0 likes Nothing to add on the substance. Thank you for taking the question at face value.
-
Amylin receptor signalling and satiety — what changed since Replied, post #6 · Pharmacology › Receptor biology · 19 Dec 2025 · 0 likes Reading back through, this was answered upthread and I missed it. My fault.
-
Tracking a preprint to publication: a worked example Replied, post #140 · Evidence › Preprints · 14 Dec 2025 · 7 likes Do not build anything on a preprint that you would mind rebuilding: if the preprint later changes substantially in revision or shows different results when published,…
-
Waist circumference technique and its repeatability Replied, post #21 · Outcomes › Progress reports · 29 Nov 2025 · 8 likes Waist circumference technique is worth one more sentence than it usually gets, and the sentence is the one about how the number was arrived at.
-
Cagrilintide's dosing interval and the pharmacokinetics behind it Replied, post #8 · Compounds › Cagrilintide & amylin analogues · 30 Sep 2025 · 1 like Picking up post #6: that is the part I would want checked first. The monoisotopic mass sits near 3749.9 Da, and the same caveat applies as everywhere else: a mass…
-
Escalating every six weeks instead of four: what I observed over eight months — one year… Replied, post #56 · Practice › Dosing & titration · 9 Sep 2025 · 13 likes The four-week step is a trial convention, not a pharmacological constant. It is roughly four half-lives for a week-long half-life, which is the interval at which you…
-
Documentation that appears only after payment Replied, post #18 · Sourcing › Red flags · 5 Sep 2025 · 27 likes Answering the question post #16 raises rather than the one it answers. A certificate that reports a specification in the result column is a documentation defect, and it…
-
How to research a compound with no human data without deceiving yourself Replied, post #39 · Compounds › Other compounds · 1 Aug 2025 · 0 likes Everything in post #37 holds. The case it does not cover is the one I have. An update on my earlier research a compound post: the pattern held for another six weeks and…
-
Reading a rodent study on a secretagogue without over-extrapolating Replied, post #30 · Compounds › Secretagogues & GH axis · 30 Jul 2025 · 0 likes The pulsatile character of endogenous growth hormone release is why a secretagogue and exogenous growth hormone are not interchangeable, and why a single measured level…
-
Why "any advice?" is the least effective ending for a post — the long version Replied, post #29 · Start Here › How to Ask · 24 Jul 2025 · 1 like Taking post #28 at face value and following it one step further. Speaking as somebody who asked badly last month and got a polite request for four missing details:…
-
Coming back to: Semaglutide half-life: where the 165 to 184 hour figure comes from Replied, post #82 · Compounds › Semaglutide · 23 Jul 2025 · 22 likes Picking up post #79: that is the part I would want checked first. On identity confirmation: a mass close to 4113.6 Da on the intact molecule is consistent with…
-
Revisiting: Why a compound being unapproved is not the same as being illegal to possess Replied, post #52 · Sourcing › Regulatory · 17 Jul 2025 · 9 likes Genuine question rather than a rhetorical one: has anyone here actually observed compound being unapproved, as opposed to read about it? The thread is long and I cannot…
-
TB-500 and thymosin beta-4: the fragment versus the protein Replied, post #18 · Compounds › Repair & healing peptides · 20 May 2025 · 1 like I had written a reply contradicting post #16 and deleted it. Here is what survived. A request rather than an answer: could whoever has the primary source for TB-500 and…
-
A well-designed study with a badly written abstract Replied, post #81 · Evidence › Study critique · 14 May 2025 · 3 likes Picking up post #80: that is the part I would want checked first. Per-protocol and intention-to-treat analyses answer different questions and neither is the honest one…
-
A supplier that answers analytical questions with restated claims Replied, post #58 · Sourcing › Red flags · 15 Apr 2025 · 7 likes Being wrong in public about a supplier is costly to that supplier and to the person who was wrong. That is why the evidence standard is what it is. The short answer was…
-
Follow-up: Open-label extensions: what survives and what does not Replied, post #2 · Evidence › Trials · 24 Feb 2025 · 0 likes Reporting rather than recommending, on Open-label extensions. What happened is above. Whether it should have is a different question and not one I am qualified to answer.
-
What SELECT changed about how semaglutide is discussed, and what it did not Replied, post #11 · Compounds › Semaglutide · 13 Feb 2025 · 0 likes Worth separating two things that post #7 runs together. Semaglutide's structure is a modified backbone with a C18 diacid attached through a spacer. The acylation is the…
-
Research-use-only labelling: what it means and what it does not — the long version Replied, post #59 · Sourcing › Regulatory · 7 Jan 2025 · 28 likes This settles it for me, at least until somebody posts a reason it should not.
-
[2026 update] New subcategory: rationale and scope Replied, post #32 · Meta › Announcements · 30 Nov 2024 · 0 likes Agreed, and I will stop repeating the version of this I had been repeating.
-
Washout with a one-week half-life: the arithmetic Replied, post #2 · Research Methods › N-of-1 designs · 21 Nov 2024 · 14 likes Sample size in n-of-1: you are the sample. Repeated measurements (weekly weighings, daily mood scores) increase the power to detect a real effect even though n=1. I…
-
Revisiting: Moderation log format change Replied, post #14 · Meta › Announcements · 2 Nov 2024 · 0 likes Post #12 and I disagree about the size of the effect, not about the direction. Noting appreciation rather than asking anything. Several years of unpaid work on…
-
What a stability-indicating method is and how you demonstrate one — one year on Replied, post #55 · Analytics › Method validation · 20 Oct 2024 · 4 likes Post #54 is right about the mechanism and I think understates the practical bit. Linearity across the working range is a routine demonstration and it constrains how far…
-
Revisiting: How to bring a laboratory report to an appointment usefully Replied, post #65 · Clinical › Bloodwork · 29 Sep 2024 · 27 likes Nobody has said the unglamorous part of bring a laboratory yet, so: most of the variation is explained by things that are boring to write about and easy to check.
-
SNAC and the mechanism of oral peptide absorption — the long version Replied, post #3 · Compounds › Oral incretins · 26 Sep 2024 · 0 likes I read the opening post twice before replying, because I had assumed the opposite. Storage for a small molecule is a different problem from storage for a peptide:…
-
How to ask for a dose change without antagonising anyone Replied, post #14 · Clinical › Prescriber conversations · 13 Aug 2024 · 12 likes A question phrased as "what would you want to see before considering X" is answerable and is not a request for X. Posting it because the silence on this was starting to…
-
Circumference measurements as a poor man's composition estimate Started this topic · Outcomes › Body composition · 14 Jul 2024 · 6 likes Posting this under the heading it deserves: Circumference measurements as a poor man's composition estimate Everything below is what sits behind that. Working notes on…